CCEL Cryo-Cell: שווי החברה בספרים

Cryo-Cell International (CCEL) relies on skilled laboratory technicians and biochemists, ensuring social security for its employees. The company manages cryobanking independently, utilizing external contractors only for the rapid delivery of biomaterials. The business operates in an autonomous cycle, remaining a defensive asset during recessions, and its indicator stands at -0.02. This price action chart on the GURU.Markets platform clearly demonstrates the issuer's market position.

Cryo-Cell International (CCEL) investments in regenerative medicine and long-term biomaterial storage establish a real asset base, minimizing the business's operational risks. The company's total book capitalization reflects the difference between asset value and liabilities, allowing investors to assess the intrinsic value of the business without market noise and determine a fair entry level based on the total book capitalization of Cryo-Cell International (CCEL).